Ireland· IE-PA-EU/1/01/172/4-5,7-8
Kaletra
A ritonavir product containing lopinavir + ritonavir, registered in Ireland by AbbVie Deutschland GmbH & Co. KG. The same ATC class is registered in 16 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Ritonavir is registered in 16 of 19 countries.
Countries holding a registration under ATC J05AE03 (ritonavir), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 9 of them publish a price we can compare per daily dose
Ritonavir · ATC J05AE03
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ritonavir costs, country by country.
Normalised to the WHO defined daily dose (1.2 g), the median price runs from $4.15 in France to $20.09 in Switzerland — a ×4.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ritonavir · price per daily dose (1.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$20.09
- FR France$4.15
The record
At a glance
HPRA (Ireland)- Active substance
- Lopinavir + Ritonavir
- Manufacturer
- AbbVie Deutschland GmbH & Co. KG
- Country
- Ireland (IE)
- ATC code
- J05AE03
- ATC class
- Ritonavir
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/01/172/4-5,7-8
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
515 interactions on record for ritonavir.
Graded by severity as the source publishes them — 149 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ritonavir · interactions on record
515 records
- 149 severe
- 238 moderate
- 19 minor
- 66 info
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- LoperamideA07DA03severe
- EluxadolineA07DA06severe
43 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ritonavir in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesKaletraAbbVie Inc.
- CzechiaKALETRAAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- FinlandKaletraAbbVie Deutschland GmbH&Co.KG
- United KingdomKaletra 100mg/25mg tabletsAbbVie Ltd
- SpainKALETRA (80 MG + 20 MG)/ML SOLUCION ORALAbbvie Deutschland Gmbh & Co. Kg
- NetherlandsKaletra (80 mg + 20 mg) /ml drankAbbVie Deutschland GmbH & Co. KG
- FranceKALETRA (80 mg + 20 mg)/ml, solution buvableABBVIE DEUTSCHLAND (ALLEMAGNE)
- PolandKaletraAbbVie Deutschland GmbH & Co. KG
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Estonia · Lopinavir/Ritonavir Ranbaxy, Lopinavir/Ritonavir Sun
- Spain · Lopinavir / Ritonavir Accord
- France · Lopinavir/Ritonavir Dextreg
- United Kingdom (Northern Ireland) · Kaletra, Lopinavir / Ritonavir Accord
- Iceland · Kaletra, Lopinavir/Ritonavir Mylan
- Liechtenstein · Kaletra, Lopinavir/Ritonavir Viatris
- Lithuania · Lopinavir / Ritonavir Sun, Lopinavir /Ritonavir Ranbaxy
- Latvia · Lopinavir/ Ritonavir Ranbaxy, Lopinavir/ Ritonavir Sun
- Netherlands · Lopinavir/Ritonavir Accord
- Norway · Kaletra, Lopinavir/Ritonavir Viatris
- Portugal · Lopinavir + Ritonavir Farmoz
- Slovenia · Lopinavir/Ritonavir Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f9ddd4cd-0747-4ded-9de7-5fd2ade0c48f GET /v1/drugs/f9ddd4cd-0747-4ded-9de7-5fd2ade0c48f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": null,
"source": "hpra",
"atc_all": [
"J05AE",
"J05AE03"
],
"strength": null,
"pa_number": "EU/1/01/172/4-5,7-8",
"substances": [
"Lopinavir",
"Ritonavir"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "27/07/2006",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about ritonavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.